Evidence map›Paper›PMID 25855729›Full record

ArticleJournal of virology2015

The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.

Luisa J Ströh, Melissa S Maginnis, Bärbel S Blaum, Christian D S Nelson, Ursula Neu, Gretchen V Gee, Bethany A O'Hara, Nasim Motamedi, Daniel DiMaio, Walter J Atwood and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Structural characterization of human neutralizing antibodies against JC and BK polyomaviruses.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Luisa J StröhInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Melissa S MaginnisDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA Department of Molecular and Biomedical Sciences, University of Maine, Orono, Maine, USA.
Bärbel S BlaumInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Christian D S NelsonDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA.
Ursula NeuInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Gretchen V GeeDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA.
Bethany A O'HaraDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA.
Nasim MotamediDepartment of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Daniel DiMaioDepartment of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Walter J AtwoodDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA walter_atwood@brown.edu thilo.stehle@uni-tuebingen.de.
Thilo StehleInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA walter_atwood@brown.edu thilo.stehle@uni-tuebingen.de.
Brown University · USUniversity of Tübingen · DEYale University · USUniversity of Maine · USVanderbilt University · US

Funding

The Maine Biomedical Research Network (INBRE)P20GM103423 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI JAMES A COFFMAN · 2012 to 2026
$60.0M
VIRAL SMALL RNPS--ROLES IN CELL TRANSFORMATIONP01CA016038 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL C. · 1985 to 2020
$25.6M
SYNTHETIC CHEMISTRY COREP01NS065719 · NINDS · BROWN UNIVERSITY · PI GEE, GRETCHEN VOGEL · 2009 to 2018
$12.3M
Center for Cancer Signaling NetworksP30GM103410 · NIGMS · BROWN UNIVERSITY · PI ATWOOD, WALTER J · 2012 to 2015
$4.3M
Release and trafficking of JC polyomavirus genomes and implications in AIDSF32NS070687 · NINDS · BROWN UNIVERSITY · PI NELSON, CHRISTIAN DOUGLAS STUART · 2010 to 2012
$153k
The Role of Viral Receptors in JCV Reactivation and Progression to PML in AIDSF32NS064870 · NINDS · BROWN UNIVERSITY · PI MAGINNIS, MELISSA · 2009 to 2011
$151k
NCI NIH HHS P01 CA016038NCI NIH HHS P01CA16038NIGMS NIH HHS P20 GM103423NIGMS NIH HHS P20GM103423NIGMS NIH HHS P30 GM103410NIGMS NIH HHS P30GM103410NINDS NIH HHS F32 NS064870NINDS NIH HHS F32NS064870NINDS NIH HHS F32 NS070687NINDS NIH HHS F32NS070687NINDS NIH HHS P01 NS065719NINDS NIH HHS PPG P01NS065719-16
6 · The paper itself

Abstract

unlabelledThe human JC polyomavirus (JCPyV) establishes an asymptomatic, persistent infection in the kidneys of the majority of the population and is the causative agent of the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML) in immunosuppressed individuals. The Mad-1 strain of JCPyV, a brain isolate, was shown earlier to require α2,6-linked sialic acid on the lactoseries tetrasaccharide c (LSTc) glycan for attachment to host cells. In contrast, a JCPyV kidney isolate type 3 strain, WT3, has been reported to interact with sialic acid-containing gangliosides, but the role of these glycans in JCPyV infection has remained unclear. To help rationalize these findings and probe the effects of strain-specific differences on receptor binding, we performed a comprehensive analysis of the glycan receptor specificities of these two representative JCPyV strains using high-resolution X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, and correlated these data with the results of infectivity assays. We show here that capsid proteins of Mad-1 and WT3 JCPyV can both engage LSTc as well as multiple sialylated gangliosides. However, the binding affinities exhibit subtle differences, with the highest affinity observed for LSTc. Engagement of LSTc is a prerequisite for functional receptor engagement, while the more weakly binding gangliosides are not required for productive infection. Our findings highlight the complexity of virus-carbohydrate interactions and demonstrate that subtle differences in binding affinities, rather than the binding event alone, help determine tissue tropism and viral pathogenesis. IMPORTANCE: Viral infection is initiated by attachment to receptors on host cells, and this event plays an important role in viral disease. We investigated the receptor-binding properties of human JC polyomavirus (JCPyV), a virus that resides in the kidneys of the majority of the population and can cause the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML) in the brains of immunosuppressed individuals. JCPyV has been reported to interact with multiple carbohydrate receptors, and we sought to clarify how the interactions between JCPyV and cellular carbohydrate receptors influenced infection. Here we demonstrate that JCPyV can engage numerous sialylated carbohydrate receptors. However, the virus displays preferential binding to LSTc, and only LSTc mediates a productive infection. Our findings demonstrate that subtle differences in binding affinity, rather than receptor engagement alone, are a key determinant of viral infection.

Indexed as

Virus AttachmentAnimalsCapsid ProteinsCrystallography, X-RayHumansJC VirusMagnetic Resonance SpectroscopyMicePolysaccharidesReceptors, VirusSialic AcidsCapsid Proteinsglycan sialylneolacto-N-tetraose cPolysaccharidesReceptors, VirusSialic Acids

Identifiers

PMID25855729
PMCPMC4474300
OpenAlexW2112911355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.